Calcitriol Injection USP · DIN 02399334 · 1 mcg/mL · injection solution Amp-1mL Pk
Off-Formulary Interchangeable, not an ODB benefitDormant since April 23, 2025 · checked October 5, 2026 · What does dormant mean? StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ministry criteria list dated January 1, 2025; the program's current criteria may differ; SADIE shows the current version. Current criteria in SADIE
Coverage criteria
Exceptional Access criteria on record are for Brand(s): Sterimax Calcitriol Injection; DOSAGE FORM/ STRENGTH: 1 mcg/mL — not this product; no criteria on record for this product in this block.
Exceptional Access Program criteria on record (ministry list dated 2025-01-01, not exhaustive):
Ministry criteria list dated January 1, 2025; the program's current criteria may differ; SADIE shows the current version. https://www.ontario.ca/page/sadie-special-authorization-digital-information-exchange
Calcitriol
Brand(s): Sterimax Calcitriol Injection
DOSAGE FORM/ STRENGTH: 1 mcg/mL
Case-by-case funding is provided for dialysis patients. Please submit all relevant
clinical data to enable an assessment by the EAP.
Calcitriol Injection, USP (calcitriol) 1mcg/mL Inj Sol – 1mL Pk (imported by STE) –
Effective Date: July 17, 2024
This imported US product (PIN 09858344) is funded under the EAP on a temporary
basis case by case and for those stabilized with an existing EAP approval. This is to
manage a product shortage of calcitriol injection 1 mcg/mL (STE) DIN 02399334 that is
funded under the EAP.
247
EAP source: eap-frequently-requested-drugs-2025-01-01.txt, page 247, record 148, corpus 2025-01-01; name match only, not an eligibility decision
1 brand, same coverage
Calcitriol Injection USP · DIN 02399334
Manufacturer: Sterimax Inc.; listing date 2016-06-29
Health Canada: Dormant since 2025-04-23 · brand CALCITRIOL INJECTION USP · ATC A11CC04 CALCITRIOL · form Solution · route Intravenous · ingredients CALCITRIOL 1 MCG/ML · company Sterimax inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCalcitriol Injection USP: Formulary list price $9.51 per unit (the source does not state the unit; exact figure $9.5132). What the ministry pays, not the patient.
Ministry pays: $9.5132 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02399334)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02399334).
DIN 02399334: Calcitriol Injection USP
Raw flags: sec3=Y, sec3b=Y, sec3bEAP=Y
Item: 881600016; group id 886; item number 2132; lccId None; manufacturer id STE
Source form: Inj Sol Amp-1mL Pk; strength: 1mcg/mL
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit; may be reimbursed through the Exceptional Access Program when approved (likely, unconfirmed)
Source prices (unrounded): $9.5132; ministry $9.5132
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02399334
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88422
Interchangeable products
Calcijex · DIN 00891738 · not recorded
Shortage status: active shortage (reported June 1, 2024, last updated August 26, 2026) · Tier 3; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02399334
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since April 23, 2025 — choose a marketed DIN from the same-category list.